| Periodo | Precio Previsto | Pasado | Histórico | Comentario |
|---|---|---|---|---|
| Mañana | $13.76 ▲ +1.68% | Ayer | $13.43 ▼ -0.71% | Tomorrow's Atrium Therapeutics Inc. Common Stock (RNA) setup is anchored to $13.53 and targets $13.76 (+1.68%). The near-term read is upside; watch $13.94 / $13.12 because daily realized volatility is about 8.00%. |
Tomorrow's Atrium Therapeutics Inc. Common Stock (RNA) setup is anchored to $13.53 and targets $13.76 (+1.68%). The near-term read is upside; watch $13.94 / $13.12 because daily realized volatility is about 8.00%. | ||||
| Semana | $14.24 ▲ +5.23% | Semana Pasada | $13.23 ▼ -2.19% | The 7-day Atrium Therapeutics Inc. Common Stock model moves from $13.23 to $14.24 (+5.23%). It gives upside momentum context for this stock, so breaks around $13.94 / $13.12 matter more than a single tick. |
The 7-day Atrium Therapeutics Inc. Common Stock model moves from $13.23 to $14.24 (+5.23%). It gives upside momentum context for this stock, so breaks around $13.94 / $13.12 matter more than a single tick. | ||||
| Mes | $15.04 ▲ +11.13% | Mes Pasado | $12.90 ▼ -4.67% | The 1-month Atrium Therapeutics Inc. Common Stock target is $15.04 (+11.13%), compared with the live reference near $13.53. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Atrium Therapeutics Inc. Common Stock target is $15.04 (+11.13%), compared with the live reference near $13.53. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Año | $16.23 ▲ +19.98% | Año Pasado | $12.39 ▼ -8.39% | The 1-year Atrium Therapeutics Inc. Common Stock scenario points to $16.23 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Atrium Therapeutics Inc. Common Stock scenario points to $16.23 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Años | $19.04 ▲ +40.71% | Hace 5 Años | $11.22 ▼ -17.10% | The 5-year Atrium Therapeutics Inc. Common Stock view is $19.04 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Atrium Therapeutics Inc. Common Stock view is $19.04 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicador | Valor | Señal |
|---|---|---|
| Price | $13.53 | Mid |
| Daily Change | -5.38% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 69% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $13.53 | Daily Change | -5.38% |
| Market Cap | $2.10B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.